Can CMV Cause Blindness If I Have HIV? Risks Explained
At a Glance
CMV retinitis can cause permanent vision loss or blindness in people with advanced or untreated HIV. It destroys the retina, may spread to the area responsible for detailed vision or the optic nerve, and can detach the retina. Urgent eye exams and antiviral treatment help protect remaining sight.
In this answer
4 sections
Yes, Cytomegalovirus (CMV) can cause severe and permanent vision loss, or even blindness, in people living with HIV [1]. However, effective HIV antiretroviral therapy (ART) has greatly reduced the occurrence of this disease; the risk is now concentrated primarily in those with untreated or very advanced HIV [2].
When the immune system is significantly weakened, the CMV virus can infect the retina (the light-sensitive tissue at the back of the eye), causing CMV retinitis. Without prompt diagnosis and treatment, this infection progressively destroys eye tissue [3].
How CMV Damages the Eye
CMV retinitis threatens vision through a few different mechanisms:
- Retinal Necrosis: The virus directly attacks and kills the cells of the retina, causing tissue death (necrosis) and bleeding within the eye [3]. While destroyed retinal tissue cannot regenerate, prompt therapy can stop the active spread of the virus, preserve your remaining vision, and prevent blindness [1].
- Spreading Infection: The infection often starts in the outer edges (peripheral retina) and progresses toward the center of the eye [3]. If it reaches the macula (the central part of the retina responsible for detailed, central vision) or the optic nerve, it can cause devastating vision loss [3][1].
- Retinal Detachment: The tissue damage and scarring caused by the infection can cause the retina to pull away or detach from the back of the eye [1]. This is a major medical emergency that requires surgical repair and is a leading cause of blindness in CMV patients [4].
Who Is at Risk and How to Screen
While anyone with advanced HIV is at risk, the danger of developing CMV retinitis is highest when your immune system is severely compromised.
- The strongest and most consistent risk factor is a CD4 count below 50 cells/mm³ [2][5].
- Medical guidelines generally recommend baseline routine screening when your CD4 count drops below 100 cells/mm³, because detecting it early is the best way to preserve vision [6][5].
How screening works:
You need a specific type of eye exam called a dilated fundus examination, performed by an ophthalmologist (an eye specialist) [7]. They will use eye drops to widen your pupils, allowing them to see the entire back of your eye. Your vision will be blurry and light-sensitive for a few hours afterward, so you should arrange for someone to drive you home.
Importantly, ordinary vision checks or blood tests for CMV cannot rule out CMV retinitis—the retina must be physically examined by an expert [8]. Your ophthalmologist and HIV care team will determine how often you need to repeat these exams while your CD4 count remains low [6].
Early Warning Signs and Your Action Plan
The most dangerous aspect of CMV retinitis is that it can be completely silent at first. In one routine ophthalmic-screening study of people with HIV, 71% of those diagnosed with CMV retinitis reported no eye symptoms at all [9].
When symptoms do appear, they include:
- New “floaters”: Small dark shapes, spots, or cobwebs drifting across your vision [10].
- Blurred vision: An overall drop in the sharpness of your sight [10][11].
- Blind spots: Missing areas or “scotomas” in your field of vision, particularly your side (peripheral) vision [12].
- Flashes of light or a dark “curtain”: Often an indicator that the retina is under severe stress or detaching [4][11].
Action Plan for Symptoms:
Do not wait for a routine appointment if you experience any of these visual changes. Seek same-day urgent eye assessment. Go to an emergency department or contact an on-call ophthalmologist immediately. Tell the healthcare staff clearly: “I have advanced HIV with a CD4 count below 50, and I need an urgent eye exam to check for CMV retinitis or retinal detachment.” [11]
Treatment: What Happens Next?
If CMV retinitis is found, it is managed through a coordinated approach:
- Immediate Anti-CMV Medications: Treatment begins with specific antiviral drugs to stop the virus [6]. The preferred first-line treatment is typically an oral antiviral pill (valganciclovir). If the infection is dangerously close to your macula or optic nerve, your doctor will likely add an injection of medication (ganciclovir) directly into your eye [13]. The eye injection is an urgent addition to your systemic pills, not a replacement for them.
- Medication Monitoring: Your doctors will carefully monitor your kidney function and complete blood counts, as these anti-CMV drugs can cause side effects like neutropenia (low white blood cells) or kidney strain [14].
- ART Coordination: If you are not already on HIV antiretroviral therapy (ART), you will usually start it roughly one to two weeks after your anti-CMV treatment begins [13]. Staggering these treatments helps prevent severe inflammation from a condition called Immune Recovery Uveitis (IRU) [15].
- Immune Recovery Uveitis (IRU): As ART rebuilds your immune system, your body may suddenly recognize and attack the CMV in your eye, causing inflammation [15][13]. IRU can cause new floaters or blurred vision. Do not stop your ART; instead, seek a prompt eye exam to manage the inflammation.
- Maintenance Therapy: You will stay on daily “maintenance” antiviral therapy until your medical team confirms several individualized milestones: your retinal lesions are completely inactive, you have finished an adequate course of initial anti-CMV therapy, and your CD4 count has safely recovered above 100 cells/mm³ for a sustained period (often 3 to 6 months) [16][13]. Follow-up eye exams will still be important even after maintenance is stopped.
Common questions in this guide
Can CMV retinitis make me blind if I have HIV?
How does CMV retinitis damage the eye?
What CD4 count puts me at greatest risk for CMV retinitis?
Can CMV retinitis be present without eye symptoms?
Which vision changes require urgent care?
How is CMV retinitis treated in people with HIV?
When can maintenance treatment for CMV retinitis be stopped?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on Cytomegalovirus Infection.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is my current CD4 count at a level where I need a baseline or repeat dilated eye exam to screen for CMV retinitis?
- 2.Are the retinal lesions near my macula or optic nerve, and will I need an intravitreal eye injection in addition to my systemic antiviral pills?
- 3.How will we coordinate the timing of my HIV antiretroviral therapy (ART) and anti-CMV medications to minimize the risk of immune recovery uveitis?
- 4.What side effects should we monitor with my current antiviral medications, particularly regarding my kidney function and blood cell counts?
- 5.What are the specific criteria we will use to decide when I can safely stop maintenance anti-CMV therapy?
References
References (16)
- 1
Incidence Rates and Risk Factors for Vision Loss among AIDS-Related Cytomegalovirus Retinitis Patients in Southern Thailand.
Sittivarakul W, Seepongphun U
Ocular immunology and inflammation 2018; (26(1)):82-89 doi:10.1080/09273948.2017.1283044.
PMID: 28323489 - 2
Prevalence and Risk Factors for Cytomegalovirus Retinitis Among People Living with HIV in Sub-Saharan Africa in the Antiretroviral Therapy Era: A Systematic Review and Meta-Analysis.
Ismail MF, Khalafalla I, Sheck ZO, et al.
Scientific reports 2026; (16(1)).
PMID: 42209549 - 3
Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and Treatment.
Zhang J, Kamoi K, Zong Y, et al.
Viruses 2024; (16(9)) doi:10.3390/v16091427.
PMID: 39339903 - 4
Antiviral therapy for cytomegalovirus retinitis: A systematic review and meta-analysis.
Putera I, La Distia Nora R, Dewi AC, et al.
Survey of ophthalmology 2025; (70(2)):215-231 doi:10.1016/j.survophthal.2024.11.004.
PMID: 39549781 - 5
Risk factors for CMV retinitis among individuals with HIV and low CD4 count in northern Thailand: importance of access to healthcare.
Leenasirimakul P, Liu Y, Jirawison C, et al.
The British journal of ophthalmology 2016; (100(8)):1017-21 doi:10.1136/bjophthalmol-2016-308556.
PMID: 27297217 - 6
Active cytomegalovirus retinitis after the start of antiretroviral therapy.
Heiden D, Tun N, Smithuis FN, et al.
The British journal of ophthalmology 2019; (103(2)):157-160 doi:10.1136/bjophthalmol-2018-312406.
PMID: 30196272 - 7
Sensitivity of the Cytomegalovirus Antigenemia Assay to Diagnose Cytomegalovirus Retinitis.
Hong SI, Kim T, Park SY, et al.
Infection & chemotherapy 2016; (48(4)):302-308 doi:10.3947/ic.2016.48.4.302.
PMID: 27883376 - 8
Cytomegalovirus retinitis in the highly active anti-retroviral therapy era.
Ude IN, Yeh S, Shantha JG
Annals of eye science 2022; (7()) doi:10.21037/aes-21-18.
PMID: 35498636 - 9
Routine Eye Screening by an Ophthalmologist Is Clinically Useful for HIV-1-Infected Patients with CD4 Count Less than 200 /μL.
Nishijima T, Yashiro S, Teruya K, et al.
PloS one 2015; (10(9)):e0136747 doi:10.1371/journal.pone.0136747.
PMID: 26375282 - 10
Clinical features of Cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome and efficacy of the current therapy.
Zhao Q, Li NN, Chen YX, Zhao XY
Frontiers in cellular and infection microbiology 2023; (13()):1107237 doi:10.3389/fcimb.2023.1107237.
PMID: 37305416 - 11
Risk factors for ocular complications in HIV/AIDS patients: a retrospective analysis of ophthalmology consultations in a tertiary hospital in Central China.
Zhang R, Zheng T, Chen X, et al.
BMC ophthalmology 2026; (26(1)).
PMID: 42174527 - 12
Diagnostic Utility of Ocular Symptoms and Vision for Cytomegalovirus Retinitis.
Liu Y, Chen AS, Kamphaengkham S, et al.
PloS one 2016; (11(10)):e0165564 doi:10.1371/journal.pone.0165564.
PMID: 27788232 - 13
International consensuses and guidelines on diagnosing and managing cytomegalovirus (CMV) retinitis by the Asia-Pacific Vitreo-retina Society (APVRS), the Asia-Pacific Professors of Ophthalmology (AAPPO) and the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII).
Hwang DK, Ng DSC, Qian Z, et al.
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2025; (14(5)):100248 doi:10.1016/j.apjo.2025.100248.
PMID: 41038280 - 14
Maribavir for cytomegalovirus retinitis: A case series and review of the literature.
Shughoury A, Emami S, Kaisari E, et al.
AJO international 2026; (3(2)) doi:10.1016/j.ajoint.2026.100247.
PMID: 41938663 - 15
Diffuse retinal dysfunction following immune reconstitution uveitis in patients with prior cytomegalovirus retinitis: a novel observation.
Yuen YS, Holder GE, Lingam G, Shen TYT
Documenta ophthalmologica. Advances in ophthalmology 2023; (147(2)):139-145 doi:10.1007/s10633-023-09947-6.
PMID: 37639171 - 16
Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort.
Jabs DA, Ahuja A, Van Natta ML, et al.
Ophthalmology 2015; (122(7)):1452-63.
PMID: 25892019
This page is for informational purposes only and does not replace professional medical advice. If you have HIV and new visual symptoms, seek same-day urgent eye care.